TY - JOUR
T1 - Surfactant Administration via Thin Catheter: A Practical Guide
AU - Vento, Maximo
AU - Bohlin, Kajsa
AU - Herting, Egbert
AU - Roehr, Charles Christoph
AU - Dargaville, Peter A.
N1 - Funding Information:
M.V. and C.C.R. received travel support and financial compensation for invited lectures from Chiesi Farmaceutici. K.B. received travel support and financial compensation for invited lectures from Chiesi Farmaceutici and served as an advisor in the development of the LISAcath. E.H. received grants and travel support from Chiesi Farmaceutici and served as an advisor for Draeger Medical, a company producing incubators, monitors, and ventilators. P.A.D. has undertaken consultancies for Chiesi Farmaceutici, Ab-bvie, and Ikaria, and served as an advisor in the development of the LISAcath.
Publisher Copyright:
© 2019 S. Karger AG, Basel. All rights reserved.
Copyright:
Copyright 2019 Elsevier B.V., All rights reserved.
PY - 2019/10/1
Y1 - 2019/10/1
N2 - Exogenous surfactant replacement is the most effective evidence-based therapy for respiratory distress syndrome in preterm infants. The mode of administration has evolved in the last decade towards less invasive techniques that aim to effectively provide an adequate dose of surfactant, while allowing spontaneous respiration to continue, and with the support of continuous positive airway pressure. Surfactant delivery via aerosolisation, pharyngeal instillation, and laryngeal mask are being actively pursued in research, but have not yet been adopted to any significant degree in clinical practice. Surfactant administration via thin catheter, on the other hand, is becoming more widely used in neonatal intensive care units worldwide and is now an acknowledged alternative to the standard mode of surfactant delivery. Different devices, including nasogastric tubes, vascular catheters, and purpose-built surfactant instillation catheters are used. We present here a contemporary review of surfactant administration via thin catheter, in a practical guide format that reflects the individual and collective scientific opinions of the clinicians who participated in formulating the guide.
AB - Exogenous surfactant replacement is the most effective evidence-based therapy for respiratory distress syndrome in preterm infants. The mode of administration has evolved in the last decade towards less invasive techniques that aim to effectively provide an adequate dose of surfactant, while allowing spontaneous respiration to continue, and with the support of continuous positive airway pressure. Surfactant delivery via aerosolisation, pharyngeal instillation, and laryngeal mask are being actively pursued in research, but have not yet been adopted to any significant degree in clinical practice. Surfactant administration via thin catheter, on the other hand, is becoming more widely used in neonatal intensive care units worldwide and is now an acknowledged alternative to the standard mode of surfactant delivery. Different devices, including nasogastric tubes, vascular catheters, and purpose-built surfactant instillation catheters are used. We present here a contemporary review of surfactant administration via thin catheter, in a practical guide format that reflects the individual and collective scientific opinions of the clinicians who participated in formulating the guide.
UR - http://www.scopus.com/inward/record.url?scp=85072065635&partnerID=8YFLogxK
U2 - 10.1159/000502610
DO - 10.1159/000502610
M3 - Scientific review articles
C2 - 31461712
AN - SCOPUS:85072065635
SN - 1661-7800
VL - 116
SP - 211
EP - 226
JO - Neonatology
JF - Neonatology
IS - 3
ER -